BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

505 related articles for article (PubMed ID: 24470190)

  • 1. Anticancer potential of (pentamethylcyclopentadienyl)chloridoiridium(III) complexes bearing κP and κP,κS-coordinated Ph2 PCH2 CH2 CH2 S(O)x Ph (x=0-2) ligands.
    Ludwig G; Ranđelović I; Maksimović-Ivanić D; Mijatović S; Bulatović MZ; Miljković D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    ChemMedChem; 2014 Jul; 9(7):1586-93. PubMed ID: 24470190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity of neutral and cationic iridium(III) complexes with κP and κP,κS coordinated Ph₂PCH₂S(O)xPh (x = 0-2) ligands.
    Ludwig G; Mijatović S; Ranđelović I; Bulatović M; Miljković D; Maksimović-Ivanić D; Korb M; Lang H; Steinborn D; Kaluđerović GN
    Eur J Med Chem; 2013 Nov; 69():216-22. PubMed ID: 24042044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.
    Ludwig G; Mojić M; Bulatović M; Mijatović S; Maksimović-Ivanić D; Steinborn D; Kaluđerović GN
    Anticancer Agents Med Chem; 2016; 16(11):1455-1460. PubMed ID: 26510901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.
    Li J; Tian M; Tian Z; Zhang S; Yan C; Shao C; Liu Z
    Inorg Chem; 2018 Feb; 57(4):1705-1716. PubMed ID: 29400963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, molecular structure, computational study and in vitro anticancer activity of dinuclear thiolato-bridged pentamethylcyclopentadienyl Rh(III) and Ir(III) complexes.
    Gupta G; Garci A; Murray BS; Dyson PJ; Fabre G; Trouillas P; Giannini F; Furrer J; Süss-Fink G; Therrien B
    Dalton Trans; 2013 Nov; 42(43):15457-63. PubMed ID: 24022745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly active neutral ruthenium(II) arene complexes: synthesis, characterization, and investigation of their anticancer properties.
    Ludwig G; Kaluđerović GN; Bette M; Block M; Paschke R; Steinborn D
    J Inorg Biochem; 2012 Aug; 113():77-82. PubMed ID: 22698819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
    Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
    Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Arene Ruthenium(II) Complexes Bearing the κ-
    Arlt S; Petković V; Ludwig G; Eichhorn T; Lang H; Rüffer T; Mijatović S; Maksimović-Ivanić D; Kaluđerović GN
    Molecules; 2021 Mar; 26(7):. PubMed ID: 33806101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.
    Yellol J; Pérez SA; Buceta A; Yellol G; Donaire A; Szumlas P; Bednarski PJ; Makhloufi G; Janiak C; Espinosa A; Ruiz J
    J Med Chem; 2015 Sep; 58(18):7310-27. PubMed ID: 26313136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
    Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
    Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.
    Li J; Tian Z; Xu Z; Zhang S; Feng Y; Zhang L; Liu Z
    Dalton Trans; 2018 Nov; 47(44):15772-15782. PubMed ID: 30357192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Valproic Acid-Functionalized Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
    Ye RR; Cao JJ; Tan CP; Ji LN; Mao ZW
    Chemistry; 2017 Oct; 23(60):15166-15176. PubMed ID: 28833658
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comparative Analysis of the In Vitro Anticancer Activity of Iridium(III) {η
    De Palo A; Draca D; Murrali MG; Zacchini S; Pampaloni G; Mijatovic S; Maksimovic-Ivanic D; Marchetti F
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alkyl chain-modified cyclometalated iridium complexes as tunable anticancer and imaging agents.
    Laha P; De U; Chandra F; Dehury N; Khullar S; Kim HS; Patra S
    Dalton Trans; 2018 Nov; 47(44):15873-15881. PubMed ID: 30358775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of anticancer activity in vitro and in vivo of iridium(III) polypyridyl complexes-loaded liposomes as drug delivery system.
    Zhang WY; Du F; He M; Bai L; Gu YY; Yang LL; Liu YJ
    Eur J Med Chem; 2019 Sep; 178():390-400. PubMed ID: 31202127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and in vitro antitumor activity of novel iridium(III) complexes with enantiopure C2-symmetrical vicinal diamine ligands.
    Yang Q; Chang J; Song J; Qian MT; Yu JM; Sun X
    Bioorg Med Chem Lett; 2013 Aug; 23(16):4602-7. PubMed ID: 23849808
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Strong Influence of the Ancillary Ligand over the Photodynamic Anticancer Properties of Neutral Biscyclometalated Ir
    Martínez-Alonso M; Busto N; Aguirre LD; Berlanga L; Carrión MC; Cuevas JV; Rodríguez AM; Carbayo A; Manzano BR; Ortí E; Jalón FA; García B; Espino G
    Chemistry; 2018 Nov; 24(66):17523-17537. PubMed ID: 30176086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant effects of counteranions on the anticancer activity of iridium(iii) complexes.
    Zhang H; Guo L; Tian Z; Tian M; Zhang S; Xu Z; Gong P; Zheng X; Zhao J; Liu Z
    Chem Commun (Camb); 2018 Apr; 54(35):4421-4424. PubMed ID: 29648559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel half-sandwich iridium(iii) imino-pyridyl complexes showing remarkable in vitro anticancer activity.
    Li J; Guo L; Tian Z; Tian M; Zhang S; Xu K; Qian Y; Liu Z
    Dalton Trans; 2017 Nov; 46(44):15520-15534. PubMed ID: 29090698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis, characterization and anticancer activity in vitro and in vivo evaluation of an iridium (III) polypyridyl complex.
    Yi QY; Wan D; Tang B; Wang YJ; Zhang WY; Du F; He M; Liu YJ
    Eur J Med Chem; 2018 Feb; 145():338-349. PubMed ID: 29331805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.